Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros











Intervalo de año de publicación
1.
Acta méd. costarric ; 65(2): 55-64, abr.-jun. 2023. tab, graf
Artículo en Español | LILACS, SaludCR | ID: biblio-1556680

RESUMEN

Resumen Las enterobacterias son un grupo amplio y heterogéneo de bacilos Gram negativos que se aíslan de forma rutinaria en el laboratorio clínico y se asocian a una gran cantidad de cuadros clínicos. Aquellas resistentes a antibióticos de última línea, como a los carbapenémicos, representan un gran reto en los centros de salud. Ante la dificultad para tratar infecciones causadas por este tipo de bacterias, se ha retomado el uso de antimicrobianos clásicos como la colistina, la nitrofurantoína y la fosfomicina. El objetivo de este trabajo es detallar los principales mecanismos de resistencia para estos tres fármacos descritos en enterobacterias. Para ello, se efectuó una revisión bibliográfica de artículos científicos publicados entre los años 1999 y 2022, utilizando las bases de datos PubMed (NCBI), PLOS, Redalyc, Google Scholar y Science Direct. En este proceso, se usaron las palabras clave "Carbapenem-Resistant Enterobacteriaceae", "colistin", nitrofurantoin", "fosfomycin", "resistance" y "plasmids". Se encontró que los mecanismos de resistencia son variados y abarcan fenómenos como modificación del sitio blanco, inactivación enzimática, impermeabilidad y eflujo. Además, los determinantes genéticos de resistencia se encuentran en cromosomas o en plásmidos. Conocer este tipo de información permite mejorar la vigilancia basada en el laboratorio, combatir el problema de resistencia a los antimicrobianos y optimizar el uso de estos antibióticos que forman parte del escaso arsenal para el tratamiento de ciertas infecciones causadas por microorganismos multidrogorresistentes.


Abstract Enterobacteriaceae is a large and heterogeneous group of Gram-negative bacilli that are routinely isolated in the clinical laboratory and are associated with a large number of clinical conditions. Those resistant to last-line antibiotics, such as carbapenems, represent a great challenge in health-care centers. Given the difficulty in treating this type of infections, the use of old drugs such as colistin, nitrofurantoin and fosfomycin has been studied. The objective of this work is to detail the main resistance mechanisms described in Enterobacteriaceae for these three antibiotics. To do this, a survey of scientific articles from the years 1999 to 2022 was carried out using databases such as PubMed (NCBI), Google Scholar, PLOS, Redalyc and Science Direct. In this process, keywords "Carbapenem- Resistant Enterobacteriaceae", "colistin", nitrofurantoin", "fosfomycin", "resistance" and "plasmids" were used. Resistance mechanisms were found to be varied and involve phenomena such as target site modification, enzyme inactivation, impermeability, and efflux. In addition, the genetic determinants of resistance are found at the chromosomal level or in plasmids. Knowing this type of information makes it possible to improve laboratory-based surveillance, fight the problem of resistance to antibiotics and take care of these antibiotics, which are part of the scarce arsenal for the treatment of certain infections caused by multidrug-resistant microorganisms.


Asunto(s)
Colistina/antagonistas & inhibidores , Enterobacteriaceae Resistentes a los Carbapenémicos , Plásmidos/antagonistas & inhibidores , Fosfomicina/antagonistas & inhibidores , Nitrofurantoína/antagonistas & inhibidores
2.
J Biol Chem ; 291(45): 23817-23829, 2016 Nov 04.
Artículo en Inglés | MEDLINE | ID: mdl-27634044

RESUMEN

Gram-negative bacteria use type IV secretion systems (T4SSs) for a variety of macromolecular transport processes that include the exchange of genetic material. The pKM101 plasmid encodes a T4SS similar to the well-studied model systems from Agrobacterium tumefaciens and Brucella suis Here, we studied the structure and function of TraE, a homolog of VirB8 that is an essential component of all T4SSs. Analysis by X-ray crystallography revealed a structure that is similar to other VirB8 homologs but displayed an altered dimerization interface. The dimerization interface observed in the X-ray structure was corroborated using the bacterial two-hybrid assay, biochemical characterization of the purified protein, and in vivo complementation, demonstrating that there are different modes of dimerization among VirB8 homologs. Analysis of interactions using the bacterial two-hybrid and cross-linking assays showed that TraE and its homologs from Agrobacterium, Brucella, and Helicobacter pylori form heterodimers. They also interact with heterologous VirB10 proteins, indicating a significant degree of plasticity in the protein-protein interactions of VirB8-like proteins. To further assess common features of VirB8-like proteins, we tested a series of small molecules derived from inhibitors of Brucella VirB8 dimerization. These molecules bound to TraE in vitro, docking predicted that they bind to a structurally conserved surface groove of the protein, and some of them inhibited pKM101 plasmid transfer. VirB8-like proteins thus share functionally important sites, and these can be exploited for the design of specific inhibitors of T4SS function.


Asunto(s)
Proteínas Bacterianas/química , Bacterias Gramnegativas/química , Plásmidos/química , Sistemas de Secreción Tipo IV/química , Agrobacterium tumefaciens/química , Agrobacterium tumefaciens/metabolismo , Secuencia de Aminoácidos , Proteínas Bacterianas/antagonistas & inhibidores , Proteínas Bacterianas/metabolismo , Brucella suis/química , Brucella suis/metabolismo , Cristalografía por Rayos X , Bacterias Gramnegativas/metabolismo , Helicobacter pylori/química , Helicobacter pylori/metabolismo , Modelos Moleculares , Plásmidos/antagonistas & inhibidores , Plásmidos/metabolismo , Conformación Proteica , Mapas de Interacción de Proteínas , Multimerización de Proteína , Bibliotecas de Moléculas Pequeñas/farmacología , Sistemas de Secreción Tipo IV/antagonistas & inhibidores , Sistemas de Secreción Tipo IV/metabolismo
3.
Chem Biol Drug Des ; 81(5): 631-44, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23350710

RESUMEN

Epstein-Barr virus (EBV) infects more than 90% of the world population. Following primary infection, Epstein-Barr virus persists in an asymptomatic latent state. Occasionally, it may switch to lytic infection. Latent EBV infection has been associated with several diseases, such as Burkitt lymphoma (BL). To date, there are no available drugs to target latent EBV, and the existing broad-spectrum antiviral drugs are mainly active against lytic viral infection. Thus, using computational molecular docking, a virtual screen of a library of small molecules, including xanthones and flavonoids (described with potential for antiviral activity against EBV), was carried out targeting EBV proteins. The more interesting molecules were selected for further computational analysis, and subsequently, the compounds were tested in the Raji (BL) cell line, to evaluate their activity against latent EBV. This work identified three novel sulfated small molecules capable of decreasing EBV levels in a BL. Therefore, the in silico screening presents a good approach for the development of new anti-EBV agents.


Asunto(s)
Antineoplásicos , Antivirales , Linfoma de Burkitt , ADN de Neoplasias , ADN Viral/antagonistas & inhibidores , Sistemas de Liberación de Medicamentos , Flavonoides , Herpesvirus Humano 4/fisiología , Plásmidos/antagonistas & inhibidores , Xantonas , Antineoplásicos/síntesis química , Antineoplásicos/química , Antineoplásicos/farmacología , Antivirales/síntesis química , Antivirales/química , Antivirales/farmacología , Linfoma de Burkitt/tratamiento farmacológico , Linfoma de Burkitt/virología , Línea Celular Tumoral , ADN de Neoplasias/antagonistas & inhibidores , ADN de Neoplasias/química , ADN de Neoplasias/metabolismo , ADN Viral/química , ADN Viral/metabolismo , Descubrimiento de Drogas , Ensayos de Selección de Medicamentos Antitumorales , Flavonoides/síntesis química , Flavonoides/química , Flavonoides/farmacología , Humanos , Plásmidos/química , Plásmidos/metabolismo , Latencia del Virus/efectos de los fármacos , Xantonas/síntesis química , Xantonas/química , Xantonas/farmacología
4.
Langmuir ; 29(2): 781-92, 2013 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-23240979

RESUMEN

A multiscale investigation was carried out to study the dark and light-enhanced bactericidal mechanisms of poly(phenylene ethynylene) (PPE)-based cationic conjugated polyelectrolytes (CPEs) and oligo-phenylene ethynylenes (OPEs). On the morphological scale, Gram-negative E. coli cells exposed to CPE and OPE compounds in the dark show damage to the cell envelope, plasma membrane, and in some cases the cytoplasm, while with UV-irradiation, E. coli sustained catastrophic damages to both the cell envelope and cytoplasm. In contrast, the Gram-positive S. epi bacteria appeared intact when exposed to CPE and OPE compounds in the dark but showed damages to the cell envelope with UV-irradiation. To better understand the molecular basis of CPE- and OPE-induced morphological changes and damages to bacteria, we investigated the effect of these compounds on model bacterial plasma membrane and bacterial proteins and plasmid DNA. Measurements of dark membrane perturbation activity of the CPEs and OPEs using model lipid membranes support a carpet or detergent-like mechanism by which the antimicrobial compounds induce membrane collapse and phase transitions. Under UV-irradiation, E. coli bacteria exposed to CPEs and OPEs showed covalent modifications and damages to both cellular protein and plasmid DNA, likely through oxidative pathways mediated by singlet oxygen and subsequent reactive oxygen species sensitized by the CPE and OPE compounds. Our finding thus show that the antimicrobial polymers and oligomers exert toxicity toward Gram-negative bacteria by disrupting the morphology and structures of cell envelope and cytoplasm, including cellular components such as proteins and DNA, while exert toxicity toward Gram-positive bacteria by binding to and disrupting just the cell wall.


Asunto(s)
Alquinos/química , Antibacterianos/farmacología , Membrana Celular/efectos de los fármacos , Pared Celular/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Éteres/química , Poliaminas/farmacología , Staphylococcus epidermidis/efectos de los fármacos , Antibacterianos/síntesis química , Proteínas Bacterianas/antagonistas & inhibidores , Proteínas Bacterianas/química , Membrana Celular/efectos de la radiación , Pared Celular/efectos de la radiación , Escherichia coli/química , Escherichia coli/efectos de la radiación , Membrana Dobles de Lípidos/efectos de la radiación , Oxidación-Reducción , Estrés Oxidativo , Plásmidos/antagonistas & inhibidores , Plásmidos/química , Poliaminas/síntesis química , Polielectrolitos , Polimerizacion , Oxígeno Singlete/química , Especificidad de la Especie , Staphylococcus epidermidis/química , Staphylococcus epidermidis/efectos de la radiación , Rayos Ultravioleta
5.
Antimicrob Agents Chemother ; 56(9): 4703-6, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22710119

RESUMEN

The treatment of infections caused by antibiotic-resistant bacteria is one of the great challenges faced by clinicians in the 21st century. Antibiotic resistance genes are often transferred between bacteria by mobile genetic vectors called plasmids. It is commonly believed that removal of antibiotic pressure will reduce the numbers of antibiotic-resistant bacteria due to the perception that carriage of resistance imposes a fitness cost on the bacterium. This study investigated the ability of the plasmid pCT, a globally distributed plasmid that carries an extended-spectrum-ß-lactamase (ESBL) resistance gene (bla(CTX-M-14)), to persist and disseminate in the absence of antibiotic pressure. We investigated key attributes in plasmid success, including conjugation frequencies, bacterial-host growth rates, ability to cause infection, and impact on the fitness of host strains. We also determined the contribution of the bla(CTX-M-14) gene itself to the biology of the plasmid and host bacterium. Carriage of pCT was found to impose no detectable fitness cost on various bacterial hosts. An absence of antibiotic pressure and inactivation of the antibiotic resistance gene also had no effect on plasmid persistence, conjugation frequency, or bacterial-host biology. In conclusion, plasmids such as pCT have evolved to impose little impact on host strains. Therefore, the persistence of antibiotic resistance genes and their vectors is to be expected in the absence of antibiotic selective pressure regardless of antibiotic stewardship. Other means to reduce plasmid stability are needed to prevent the persistence of these vectors and the antibiotic resistance genes they carry.


Asunto(s)
Farmacorresistencia Microbiana/genética , Escherichia coli/genética , Secuencias Repetitivas Esparcidas , Plásmidos/genética , Salmonella typhimurium/genética , beta-Lactamasas/genética , Animales , Antibacterianos , Caenorhabditis elegans/microbiología , Conjugación Genética , Escherichia coli/patogenicidad , Aptitud Genética , Mutagénesis Insercional , Plásmidos/antagonistas & inhibidores , Salmonella typhimurium/patogenicidad , Inhibidores de beta-Lactamasas
6.
Mol Ther ; 19(8): 1478-86, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21540836

RESUMEN

Nonviral vectors present considerable advantages over viral counterparts in gene transfer. However, the poor expression efficiency of the transfected genes poses a challenge for their use in gene therapy, primarily due to the inability of these vectors to overcome various barriers, including the biological barriers. Here, we report that ZNF511-PRAP1 may be involved in the recognition and inactivation of transfected plasmids. ZNF511-PRAP1 is induced by transfection of plasmid DNA and suppresses the transcription of transfected plasmids. It binds directly to the p21 promoter in transfected plasmids but not the endogenous counterpart. Similarly, ZNF511-PRAP1 suppresses the expression of the green fluorescent protein reporter gene on transiently transfected plasmids but not an integrated red fluorescence reporter gene with the same cytomegalovirus (CMV) promoter. Therefore, ZNF511-PRAP1 is able to differentiate between exogenous/nonintegrated and endogenous/integrated DNA. The suppression by ZNF511-PRAP1 is independent of DNA methylation and can be abolished by trichostatin A (TSA) treatment and knockdown of HDAC2 and/or ZNF511-PRAP1. Furthermore, ZNF511-PRAP1 interacts directly with HDAC2. Our results revealed that transfected plasmids are recognized by ZNF511-PRAP1 and suppressed by a repressor complex comprising ZNF511-PRAP1 and HDAC2 and suggest that ZNF511-PRAP1 could play a role as a potential molecular barrier in nonviral transgene expression.


Asunto(s)
Proteínas Portadoras/metabolismo , Expresión Génica , Técnicas de Transferencia de Gen , Plásmidos/genética , Proteínas Gestacionales/metabolismo , Factores de Transcripción/metabolismo , Transgenes/genética , Proteínas Portadoras/genética , Línea Celular Tumoral , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/genética , Genes Reporteros , Terapia Genética/métodos , Vectores Genéticos , Histona Desacetilasa 2/genética , Histona Desacetilasa 2/metabolismo , Humanos , Ácidos Hidroxámicos/farmacología , Plásmidos/antagonistas & inhibidores , Plásmidos/metabolismo , Proteínas Gestacionales/genética , Regiones Promotoras Genéticas , ARN Interferente Pequeño/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Factores de Transcripción/efectos de los fármacos , Transfección
7.
J Inorg Biochem ; 101(8): 1153-64, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17592741

RESUMEN

The presence of polyamines in living cells is crucial for survival. Due to their high net charge at physiological pH, polyamines effectively charge neutralize the phosphodiester backbone of DNA in an interaction that also may protect the DNA from external damage. We here present a study illustrating the influence of spermidine and spermine on the platination reactions of the model oligonucleotides d(T(6)GT(6)), d(T(12)GT(12)), and d(T(24)GT(24)), and the pUC18 DNA plasmid. The aquated forms of the anticancer active compounds cisplatin (cis-[Pt(NH(3))(2)Cl(2)]) and the major Pt(II) metabolite of JM216 (cis-[PtCl(2)(NH(3))(c-C(6)H(11)NH(2))], JM118) were used as platination reagents. The study shows that the kinetics for formation of the coordinative Pt-DNA adduct are strongly influenced by the presence of sub-millimolar polyamine concentrations. At polyamine concentrations in the muM-range, the reactions remain salt-dependent. In contrast, platination of pUC18 is effectively prevented at mM concentrations of both spermidine and spermine with the latter as the more potent inhibitor. The results suggest that variations of intracellular polyamine concentrations may have a profound influence on the efficacy by which cationically charged reagents interfere with DNA function in vivo by modulation of the preassociation conditions.


Asunto(s)
Aductos de ADN/antagonistas & inhibidores , ADN de Cadena Simple/antagonistas & inhibidores , Oligonucleótidos/antagonistas & inhibidores , Compuestos de Platino/antagonistas & inhibidores , Espermidina/farmacología , Espermina/farmacología , Cationes Monovalentes , Aductos de ADN/metabolismo , ADN de Cadena Simple/metabolismo , Relación Dosis-Respuesta a Droga , Cinética , Oligonucleótidos/metabolismo , Plásmidos/antagonistas & inhibidores , Plásmidos/metabolismo , Compuestos de Platino/metabolismo , Sodio/química , Sodio/metabolismo
8.
Chromosoma ; 112(2): 58-65, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12883945

RESUMEN

The yeast retrotransposon Ty 5 integrates preferentially into heterochromatin at the telomeres and HM loci. Target specificity is mediated by a six amino acid sequence motif (the targeting domain, TD) of integrase that interacts with Sir4p, a structural component of heterochromatin. When tethered to CEN plasmids as part of a Gal4p DNA binding domain (GBD) fusion protein, TD destabilizes plasmid segregation in a manner similar to that observed for CEN + HM or CEN +TEL antagonism. This instability is caused by the ability of TD to nucleate components of heterochromatin on the CEN plasmid, because CEN +TD antagonism is abrogated by sir2, sir3 and sir4 mutations and by TD mutations that prevent interaction with Sir4p. In strains that acquire resistance to CEN +TD antagonism, the CEN plasmid has either recombined with a 2 mu plasmid or sustained deletions in sequences required to bind GBD-TD. CEN +TD and CEN + HM antagonism is exacerbated by mutations in components of the Ku-mediated non-homologous end-joining pathway. These observations suggest that CEN antagonism is caused by DNA breaks that result from competition between CEN - and Sir-specific segregation pathways.


Asunto(s)
Reparación del ADN/fisiología , ADN de Hongos/metabolismo , Plásmidos/antagonistas & inhibidores , Retroelementos , Proteínas Reguladoras de Información Silente de Saccharomyces cerevisiae/metabolismo , Telómero/metabolismo , Secuencias de Aminoácidos , Daño del ADN , Heterocromatina/metabolismo , Integrasas/química , Integrasas/metabolismo , Modelos Biológicos , Proteínas Recombinantes de Fusión/metabolismo , Saccharomyces cerevisiae/genética , Proteínas Reguladoras de Información Silente de Saccharomyces cerevisiae/química , Proteínas Reguladoras de Información Silente de Saccharomyces cerevisiae/genética , Telómero/genética
9.
Biochemistry ; 41(16): 5255-65, 2002 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-11955075

RESUMEN

Plasmid DNA replication in nuclear extracts of Saccharomyces cerevisiae in vitro has been shown to be S-phase specific, similar to that observed in vivo. We report here a reconstituted in vitro system with partially purified replication proteins, purified replication protein A (RPA), and recombinant proliferating cell nuclear antigen (PCNA). Nuclear extracts from S-phase, G(1)-phase, and unsynchronized yeast cells were fractionated by phosphocellulose chromatography. Protein fraction (polymerase fraction) enriched with replication proteins, including DNA polymerases (alpha, delta, etc.), was isolated, which was not capable of in vitro replication of supercoiled plasmid DNA. However, when purified yeast RPA and recombinant PCNA together were added to the polymerase fraction obtained from S-phase synchronized cells, in vitro plasmid DNA replication was restored. In vitro plasmid DNA replication with polymerase fractions from unsynchronized and G(1)-phase cells could not be reconstituted upon addition of purified RPA and PCNA. RPA and PCNA isolated from various phases of the cell cycle complemented the S-phase polymerase pool to the same extent. Reconstituted systems with the S-phase polymerase pool, complemented with either the RPA- and PCNA-containing fraction or purified RPA and recombinant PCNA together, were able to produce replication intermediates (ranging in size from 50 to 1500 bp) similar to that observed with the S-phase nuclear extract. Results presented here demonstrate that both RPA and PCNA are cell cycle-independent in their ability to stimulate in vitro plasmid DNA replication, whereas replication factors in the polymerase fractions are strictly S-phase dependent.


Asunto(s)
Ciclo Celular/genética , Celulosa/análogos & derivados , ADN de Hongos/biosíntesis , Proteínas de Unión al ADN/metabolismo , Proteínas Fúngicas/genética , Proteínas Nucleares/genética , Plásmidos/biosíntesis , Antígeno Nuclear de Célula en Proliferación/metabolismo , Saccharomyces cerevisiae/genética , Animales , Afidicolina/farmacología , Resinas de Intercambio de Catión , Ciclo Celular/efectos de los fármacos , Núcleo Celular/genética , Núcleo Celular/metabolismo , Cromatografía por Intercambio Iónico , Replicación del ADN/genética , ADN de Hongos/antagonistas & inhibidores , ADN de Hongos/genética , ADN de Hongos/metabolismo , ADN Superhelicoidal/biosíntesis , Proteínas de Unión al ADN/análisis , Proteínas de Unión al ADN/antagonistas & inhibidores , Proteínas de Unión al ADN/aislamiento & purificación , ADN Polimerasa Dirigida por ADN/metabolismo , Electroforesis en Gel de Poliacrilamida , Proteínas Fúngicas/antagonistas & inhibidores , Proteínas Fúngicas/biosíntesis , Proteínas Fúngicas/metabolismo , Fase G1/genética , Inhibidores de Crecimiento/farmacología , Sueros Inmunes/farmacología , Ratones , Proteínas Nucleares/antagonistas & inhibidores , Proteínas Nucleares/biosíntesis , Proteínas Nucleares/metabolismo , Desnaturalización de Ácido Nucleico , Plásmidos/antagonistas & inhibidores , Antígeno Nuclear de Célula en Proliferación/análisis , Proteína de Replicación A , Fase S/genética , Saccharomyces cerevisiae/citología
10.
Indian J Exp Biol ; 37(7): 671-5, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10522156

RESUMEN

Thioridazine (Th), which is therapeutically used in psychiatric patients, was found to possess conspicuous antimicrobial activity when tested against 316 strains belonging to a number of Gram positive and Gram negative bacteria. Although Staphylococcus aureus, Vibrio chloerae and V. parahaemolyticus were found to be most sensitive, Th was highly bactericidal against S. aureus and bacteriostatic for vibrios and other Gram negative organisms. In the study of antiplasmid/curing effect of Th on twelve multiply antibiotic and Th resistant bacteria, it was observed that elimination of R plasmids was facilitated by choice of optimal concentration of Th. Significant elimination of single and combined antibiotic resistance occurred in E. coli and Shigella flexneri and not in S. aureus.


Asunto(s)
Antibacterianos/farmacología , Plásmidos/antagonistas & inhibidores , Tioridazina/farmacología , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Pruebas de Sensibilidad Microbiana
11.
J Immunol ; 163(1): 295-300, 1999 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-10384128

RESUMEN

Although tightly linked, the TCR alpha and delta genes are expressed specifically in T lymphocytes, whereas the Dad1 gene is ubiquitously expressed. Between TCR alpha and Dad1 are eight DNase I hypersensitive sites (HS). HS1 colocalizes with the TCR alpha enhancer (Ealpha) and is T cell-specific; HS2, -3, -4, -5, and -6 map downstream of HS1 and are tissue-nonspecific. The region spanning HS2-6 was reported to display chromatin-opening activity and to confer copy number-dependent and integration site-independent transgene expression in transgenic mice. Here, we demonstrate that HS2-6 also displays enhancer-blocking activity, as it can block an enhancer from activating a promoter when located between the two in a chromatin-integrated context, and can do so without repressing either the enhancer or the promoter. Multiple enhancer-blocking elements are arrayed across HS2-6. We show that HS2-6 by itself does not activate transcription in chromatin context, but can synergize with an enhancer when located upstream of an enhancer and promoter. We propose that HS2-6 primarily functions as an insulator or boundary element that may be critical for the autonomous regulation of the TCR alpha and Dad1 genes.


Asunto(s)
Cinamatos , Desoxirribonucleasa I/metabolismo , Elementos de Facilitación Genéticos/inmunología , Genes Codificadores de la Cadena alfa de los Receptores de Linfocito T , Proteínas de la Membrana/genética , Secuencias Reguladoras de Ácidos Nucleicos/inmunología , Animales , Proteínas Reguladoras de la Apoptosis , Regulación de la Expresión Génica/inmunología , Humanos , Higromicina B/análogos & derivados , Higromicina B/antagonistas & inhibidores , Higromicina B/biosíntesis , Células Jurkat , Región de Control de Posición/inmunología , Ratones , Neomicina/antagonistas & inhibidores , Neomicina/biosíntesis , Plásmidos/antagonistas & inhibidores , Plásmidos/síntesis química , Regiones Promotoras Genéticas/inmunología
12.
Yeast ; 11(1): 1-14, 1995 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-7762296

RESUMEN

We have constructed 2-micron-based yeast expression vectors containing a copy of the metallothionein (CUP1) gene of Saccharomyces cerevisiae as a semi-dominant, selectable marker. When used for the expression of the thrombin inhibitor hirudin, originally derived from the leech Hirudo medicinalis, these vectors displayed the following characteristics. (1) In the presence of copper salts, they were mitotically more stable than similarly designed control vectors lacking the CUP1 gene. In copper-sensitive host strains, the apparent plasmid stability was 100%, even in complex media and during fed-batch fermentation for an extended period of time. (2) Use of the CUP1-stabilized plasmids improved the production of hirudin by both copper-sensitive and copper-resistant hosts. The highest hirudin titers were obtained with a delta CUP1 host. (3) Copper selection resulted in a moderate increase in average plasmid copy numbers (up to two-fold) as assessed by measuring hirudin expression from a constitutive promoter (GAPFL). This effect was most noticeable if the vector showed an asymmetric segregation pattern (i.e., high rates of plasmid loss in the absence of copper). (4) The CUP1 marker proved particularly useful in combination with a CUP1-promoter-controlled expression cassette on the same plasmid. In such a set-up, the rates of transcription of the heterologous protein and that of the selectable marker are tightly linked. Therefore, an increase in selective pressure directly provokes an increase in product yields. In a copper-sensitive host strain, this plasmid design allowed for the production of very high amounts of biologically active hirudin. Our results clearly establish the utility of the CUP1 marker in the construction of stable yeast expression vectors.


Asunto(s)
Marcadores Genéticos/genética , Vectores Genéticos/genética , Metalotioneína/genética , Saccharomyces cerevisiae/genética , Proteínas Portadoras , Mapeo Cromosómico , Cobre/metabolismo , Cobre/farmacología , Medios de Cultivo , Dosificación de Gen , Regulación Fúngica de la Expresión Génica/genética , Genes Fúngicos , Hirudinas/genética , Hirudinas/metabolismo , Plásmidos/antagonistas & inhibidores , Plásmidos/genética , Regiones Promotoras Genéticas/genética , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/crecimiento & desarrollo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA